Acceleron Pharma, Inc., A Wholly-owned Subsidiary Of Merck & Co., Inc., Rahway, Nj Usa

This study tested a drug called sotatercept in people newly diagnosed with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. The goal was to see if adding sotatercept to standard treatment could delay worsening of the disease. The tria…